25645581|t|Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
25645581|a|The clinical symptoms of Alzheimer disease (AD) include a gradual memory loss and subsequent dementia, and neuropathological deposition of senile plaques and neurofibrillary tangles. At the molecular level, AD subjects present overt amyloid beta (Abeta) production and tau hyperphosphorylation. Abeta species have been proposed to overactivate the phosphoinositide3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) axis, which plays a central role in proteostasis. The current study investigated the status of the PI3K/Akt/mTOR pathway in post-mortem tissue from the inferior parietal lobule (IPL) at three different stages of AD: late AD, amnestic mild cognitive impairment (MCI) and pre-clinical AD (PCAD). Our findings suggest that the alteration of mTOR signaling and autophagy occurs at early stages of AD. We found a significant increase in Abeta (1-42) levels, associated with reduction in autophagy (Beclin-1 and LC-3) observed in PCAD, MCI, and AD subjects. Related to the autophagy impairment, we found a hyperactivation of PI3K/Akt/mTOR pathway in IPL of MCI and AD subjects, but not in PCAD, along with a significant decrease in phosphatase and tensin homolog. An increase in two mTOR downstream targets, p70S6K and 4EBP1, occurred in AD and MCI subjects. Both AD and MCI subjects showed increased, insulin receptor substrate 1, a candidate biomarker of brain insulin resistance, and GSK-3beta, a kinase targeting tau phosphorylation. Nevertheless, tau phosphorylation was increased in the clinical groups. The results hint at a link between Abeta and the PI3K/Akt/mTOR axis and provide further insights into the relationship between AD pathology and insulin resistance. In addition, we speculate that the alteration of mTOR signaling in the IPL of AD and MCI subjects, but not in PCAD, is due to the lack of substantial increase in oxidative stress. The figure represents the three different stages of Alzheimer Disease: Preclinical Alzheimer Disease (PCAD), Mild cognitive impairment (MCI) and late stage of Alzheimer Disease. The progression of the disease is associated with a reduction in autophagy (Beclin-1 and LC-3) observed in Inferior parietal lobe of PCAD, MCI, and AD subjects (light red). Related to the autophagy impairment, the graph shows the impairment of PI3K/Akt/mTOR in MCI and AD subjects (dark red). 
25645581	14	18	mTOR	Gene	2475
25645581	64	81	Alzheimer disease	Disease	MESH:D000544
25645581	83	85	AD	Disease	MESH:D000544
25645581	138	140	AD	Disease	MESH:D000544
25645581	151	176	mild cognitive impairment	Disease	MESH:D060825
25645581	192	194	AD	Disease	MESH:D000544
25645581	221	238	Alzheimer disease	Disease	MESH:D000544
25645581	240	242	AD	Disease	MESH:D000544
25645581	262	273	memory loss	Disease	MESH:D008569
25645581	289	297	dementia	Disease	MESH:D003704
25645581	342	349	plaques	Disease	MESH:D003773
25645581	354	377	neurofibrillary tangles	Disease	MESH:D055956
25645581	403	405	AD	Disease	MESH:D000544
25645581	429	441	amyloid beta	Gene	351
25645581	443	448	Abeta	Gene	351
25645581	465	468	tau	Gene	4137
25645581	491	496	Abeta	Gene	351
25645581	544	568	phosphoinositide3-kinase	Gene	5293
25645581	576	579	Akt	Gene	207
25645581	580	609	mammalian target of rapamycin	Gene	2475
25645581	611	615	mTOR	Gene	2475
25645581	721	724	Akt	Gene	207
25645581	725	729	mTOR	Gene	2475
25645581	829	831	AD	Disease	MESH:D000544
25645581	838	840	AD	Disease	MESH:D000544
25645581	851	876	mild cognitive impairment	Disease	MESH:D060825
25645581	878	881	MCI	Disease	MESH:D060825
25645581	900	902	AD	Disease	MESH:D000544
25645581	904	908	PCAD	Disease	MESH:D000544
25645581	955	959	mTOR	Gene	2475
25645581	1010	1012	AD	Disease	MESH:D000544
25645581	1110	1118	Beclin-1	Gene	8678
25645581	1123	1127	LC-3	Gene	84557
25645581	1141	1145	PCAD	Disease	MESH:D000544
25645581	1147	1150	MCI	Disease	MESH:D060825
25645581	1156	1158	AD	Disease	MESH:D000544
25645581	1241	1244	Akt	Gene	207
25645581	1245	1249	mTOR	Gene	2475
25645581	1268	1271	MCI	Disease	MESH:D060825
25645581	1276	1278	AD	Disease	MESH:D000544
25645581	1300	1304	PCAD	Disease	MESH:D000544
25645581	1343	1373	phosphatase and tensin homolog	Gene	5728
25645581	1394	1398	mTOR	Gene	2475
25645581	1419	1425	p70S6K	Gene	6198
25645581	1430	1435	4EBP1	Gene	1978
25645581	1449	1451	AD	Disease	MESH:D000544
25645581	1456	1459	MCI	Disease	MESH:D060825
25645581	1475	1477	AD	Disease	MESH:D000544
25645581	1482	1485	MCI	Disease	MESH:D060825
25645581	1513	1541	insulin receptor substrate 1	Gene	3667
25645581	1574	1592	insulin resistance	Disease	MESH:D007333
25645581	1598	1607	GSK-3beta	Gene	2932
25645581	1628	1631	tau	Gene	4137
25645581	1663	1666	tau	Gene	4137
25645581	1756	1761	Abeta	Gene	351
25645581	1775	1778	Akt	Gene	207
25645581	1779	1783	mTOR	Gene	2475
25645581	1848	1850	AD	Disease	MESH:D000544
25645581	1865	1883	insulin resistance	Disease	MESH:D007333
25645581	1934	1938	mTOR	Gene	2475
25645581	1963	1965	AD	Disease	MESH:D000544
25645581	1970	1973	MCI	Disease	MESH:D060825
25645581	1995	1999	PCAD	Disease	MESH:D000544
25645581	2117	2134	Alzheimer Disease	Disease	MESH:D000544
25645581	2148	2165	Alzheimer Disease	Disease	MESH:D000544
25645581	2167	2171	PCAD	Disease	MESH:D000544
25645581	2174	2199	Mild cognitive impairment	Disease	MESH:D060825
25645581	2201	2204	MCI	Disease	MESH:D060825
25645581	2224	2241	Alzheimer Disease	Disease	MESH:D000544
25645581	2319	2327	Beclin-1	Gene	8678
25645581	2332	2336	LC-3	Gene	84557
25645581	2376	2380	PCAD	Disease	MESH:D000544
25645581	2382	2385	MCI	Disease	MESH:D060825
25645581	2391	2393	AD	Disease	MESH:D000544
25645581	2492	2495	Akt	Gene	207
25645581	2496	2500	mTOR	Gene	2475
25645581	2504	2507	MCI	Disease	MESH:D060825
25645581	2512	2514	AD	Disease	MESH:D000544
25645581	Association	MESH:D060825	3667
25645581	Positive_Correlation	207	351
25645581	Association	MESH:D060825	2475
25645581	Association	MESH:D060825	4137
25645581	Association	2475	6198
25645581	Negative_Correlation	MESH:D060825	5728
25645581	Association	MESH:D060825	2932
25645581	Association	MESH:D060825	8678
25645581	Association	2932	4137
25645581	Positive_Correlation	MESH:D060825	1978
25645581	Positive_Correlation	MESH:D060825	207
25645581	Association	MESH:D060825	84557
25645581	Association	MESH:D000544	351
25645581	Association	351	4137
25645581	Positive_Correlation	MESH:D060825	6198
25645581	Positive_Correlation	2475	351
25645581	Association	1978	2475
25645581	Negative_Correlation	MESH:D000544	84557
25645581	Positive_Correlation	351	5293
25645581	Association	MESH:D000544	2475
25645581	Association	MESH:D000544	4137
25645581	Negative_Correlation	MESH:D000544	8678
25645581	Association	MESH:D000544	207
25645581	Association	MESH:D007333	3667
25645581	Association	207	2475

